NANT Ovarian Cancer Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NANT Ovarian Cancer Vaccine, covering 2025-02-21 to 2025-02-21. Get the full timeline:
Most recent: Clinical Trial Update: QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy [Phase 1, Phase 2]